Standout Papers
Citation Impact
Citing Papers
Outcomes After Stereotactic Body Radiotherapy or Radiofrequency Ablation for Hepatocellular Carcinoma
2015
Colorectal cancer statistics, 2020
2020 Standout
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
Colorectal cancer statistics, 2023
2023 Standout
Stereotactic body radiation therapy vs. radiofrequency ablation in Asian patients with hepatocellular carcinoma
2020
Engineering precision nanoparticles for drug delivery
2020 Standout
Radiotherapy for renal-cell carcinoma
2014
Epidemiology, management and prognosis of colorectal cancer with lung metastases: a 30-year population-based study
2010
Comparative Analysis of Resection and Liver Transplantation for Intrahepatic and Hilar Cholangiocarcinoma
2011
Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2014 Standout
Hepatocellular carcinoma
2018 Standout
Improving target delineation on 4-dimensional CT scans in stage I NSCLC using a deformable registration tool
2010
Combining CXCL10 gene therapy and radiotherapy improved therapeutic efficacy in cervical cancer HeLa cell xenograft tumor models
2015
A prospective Phase II trial of using extracranial stereotactic radiotherapy in primary and metastatic renal cell carcinoma
2006
ERS/ESTS clinical guidelines on fitness for radical therapy in lung cancer patients (surgery and chemo-radiotherapy)
2009 Standout
Individualized treatment in stage IVC nasopharyngeal carcinoma
2014
Sphingolipids and their metabolism in physiology and disease
2017 Standout
Long-term multi-institutional analysis of stage T1–T2 prostate cancer treated with radiotherapy in the PSA era
2003
Metastatic non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2016 Standout
Stereotactic Body Radiation Therapy for Inoperable Early Stage Lung Cancer
2010 Standout
Phytochemicals in Cancer Treatment: From Preclinical Studies to Clinical Practice
2020 Standout
Stereotactic body radiation therapy for oligometastases
2009
Stereotactic body radiation therapy: a novel treatment modality
2009
Radiomics: Images Are More than Pictures, They Are Data
2015 Standout
Recent advances in strategies for immunotherapy of human papillomavirus‐induced lesions
2007
Predictive Index for Tumor Recurrence after Liver Transplantation for Locally Advanced Intrahepatic and Hilar Cholangiocarcinoma
2011
Nasopharyngeal carcinoma
2019 Standout
Hepatocellular carcinoma
2021 Standout
Local Surgical, Ablative, and Radiation Treatment of Metastases
2009
BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update
2021 Standout
Multicenter results of stereotactic body radiotherapy (SBRT) for non-resectable primary liver tumors
2012
Treatments for colorectal liver metastases: A new focus on a familiar concept
2016
Colorectal cancer
2013 Standout
Liver-Directed Radiotherapy for Hepatocellular Carcinoma
2016
Bevacizumab plus Radiotherapy–Temozolomide for Newly Diagnosed Glioblastoma
2014 Standout
The oligometastatic state—separating truth from wishful thinking
2014
Lung cancer: current therapies and new targeted treatments
2016 Standout
Cell-free nucleic acids as biomarkers in cancer patients
2011 Standout
Pyroptosis: mechanisms and diseases
2021 Standout
Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2017 Standout
Accreditation and quality assurance for Radiation Therapy Oncology Group: Multicenter clinical trials using Stereotactic Body Radiation Therapy in lung cancer
2006
Stereotactic radiotherapy for oligometastatic cancer: a prognostic model for survival
2013
Nasopharyngeal carcinoma
2015 Standout
Clinical Outcomes of Intensity-Modulated Pelvic Radiation Therapy for Carcinoma of the Cervix
2010
Role of radiotherapy in the management of hepatocellular carcinoma: A systematic review
2015
Stereotactic Body Radiation Therapy as an Alternative Treatment for Small Hepatocellular Carcinoma
2013
Cancer and Radiation Therapy: Current Advances and Future Directions
2012 Standout
Local Ablative Therapy of Oligoprogressive Disease Prolongs Disease Control by Tyrosine Kinase Inhibitors in Oncogene-Addicted Non–Small-Cell Lung Cancer
2012
The role of local therapy in the management of lung and liver oligometastases
2011
Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma
2014 Standout
Safety and Efficacy of Bevacizumab With Hypofractionated Stereotactic Irradiation for Recurrent Malignant Gliomas
2009
Macrophages as regulators of tumour immunity and immunotherapy
2019 Standout
An inhalable nanoparticulate STING agonist synergizes with radiotherapy to confer long-term control of lung metastases
2019
EAU Guidelines on Renal Cell Carcinoma: 2014 Update
2015 Standout
Endothelial Membrane Remodeling Is Obligate for Anti-Angiogenic Radiosensitization during Tumor Radiosurgery
2010
Radiation-Associated Liver Injury
2010
Inhibition of PI3K/Akt/mTOR pathway by apigenin induces apoptosis and autophagy in hepatocellular carcinoma cells
2018 Standout
Local treatments for metastases of renal cell carcinoma: a systematic review
2014
Rib fracture after stereotactic radiotherapy for primary lung cancer: prevalence, degree of clinical symptoms, and risk factors
2013
American Society for Therapeutic Radiology and Oncology (ASTRO) and American College of Radiology (ACR) Practice Guideline for the Performance of Stereotactic Body Radiation Therapy
2010
Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2018 Standout
Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: Recommendations of the RTOG-ASTRO Phoenix Consensus Conference
2006 Standout
The impact of respiratory motion and treatment technique on stereotactic body radiation therapy for liver cancer
2008
Cervical cancer
2019 Standout
Recent progress in understanding, diagnosing, and treating hepatocellular carcinoma
2012
American Society for Therapeutic Radiology and Oncology* and American College of Radiology Practice Guideline for the Performance of Stereotactic Body Radiation Therapy
2004
Radiation-induced autophagy potentiates immunotherapy of cancer via up-regulation of mannose 6-phosphate receptor on tumor cells in mice
2014
Orthotopic liver transplantation in combination with neoadjuvant therapy
2012
Hepatocellular carcinoma
2022 Standout
Development of Virus-Like Particle Technology from Small Highly Symmetric to Large Complex Virus-Like Particle Structures
2013 Standout
Sequential Phase I and II Trials of Stereotactic Body Radiotherapy for Locally Advanced Hepatocellular Carcinoma
2013
Management of glioblastoma: State of the art and future directions
2020 Standout
Individualized Adaptive Stereotactic Body Radiotherapy for Liver Tumors in Patients at High Risk for Liver Damage
2017
European Organisation for Research and Treatment of Cancer Recommendations for Planning and Delivery of High-Dose, High-Precision Radiotherapy for Lung Cancer
2010
Algorithms at Work: The New Contested Terrain of Control
2019 Standout
Radical Treatment of Non–Small-Cell Lung Cancer Patients with Synchronous Oligometastases: Long-Term Results of a Prospective Phase II Trial (Nct01282450)
2012
Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): Explanation and Elaboration
2015 Standout
Extracranial Oligometastases: A Subset of Metastases Curable With Stereotactic Radiotherapy
2013
ICRP PUBLICATION 118: ICRP Statement on Tissue Reactions and Early and Late Effects of Radiation in Normal Tissues and Organs — Threshold Doses for Tissue Reactions in a Radiation Protection Context
2012 Standout
Excessive Toxicity When Treating Central Tumors in a Phase II Study of Stereotactic Body Radiation Therapy for Medically Inoperable Early-Stage Lung Cancer
2006
Mertk on tumor macrophages is a therapeutic target to prevent tumor recurrence following radiation therapy
2016
Stereotactic Body Radiation Therapy in Multiple Organ Sites
2007
Nanotechnology for Multimodal Synergistic Cancer Therapy
2017 Standout
Renegotiating Spheres of Obligation: The Role of Hierarchy in Organizational Learning
2017
Colorectal cancer statistics, 2017
2017 Standout
Prospective Study of Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma on Waitlist for Liver Transplant
2021
Combining Radiation and Immunotherapy: A New Systemic Therapy for Solid Tumors?
2014 StandoutNobel
Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases
2018 Standout
Radiotherapy combination opportunities leveraging immunity for the next oncology practice
2016
Stereotactic ablative radiotherapy for hepatocellular carcinoma: A systematic review and meta‐analysis of local control, survival and toxicity outcomes
2021
PD-L1 Expression as a Predictive Biomarker in Cancer Immunotherapy
2015 Standout
Reactive Oxygen Species (ROS)-Based Nanomedicine
2019 Standout
Strategies for Combining Immunotherapy with Radiation for Anticancer Therapy
2015 StandoutNobel
Emergence of Stereotactic Body Radiation Therapy and Its Impact on Current and Future Clinical Practice
2014
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
2018 Standout
Predictive Utility of Circulating Methylated DNA in Serum of Melanoma Patients Receiving Biochemotherapy
2005
Consolidative Radiotherapy for Limited Metastatic Non–Small-Cell Lung Cancer
2017
Irradiation and anti–PD-L1 treatment synergistically promote antitumor immunity in mice
2014 Standout
Stereotactic Body Radiation Therapy: Scope of the Literature
2011
Guideline for Management of the Clinical T1 Renal Mass
2009 Standout
Licochalcone A induces autophagy through PI3K/Akt/mTOR inactivation and autophagy suppression enhances Licochalcone A-induced apoptosis of human cervical cancer cells
2015
Works of Tracey E. Schefter being referenced
Stereotactic body radiotherapy for colorectal liver metastases
2011
Microscopic and Macroscopic Tumor and Parenchymal Effects of Liver Stereotactic Body Radiotherapy
2008
Chest Wall Volume Receiving >30 Gy Predicts Risk of Severe Pain and/or Rib Fracture After Lung Stereotactic Body Radiotherapy
2009
Stereotactic body radiation therapy for melanoma and renal cell carcinoma: impact of single fraction equivalent dose on local control
2011
Phase I feasibility trial of stereotactic body radiation therapy for primary hepatocellular carcinoma
2010
Consensus Guidelines for Delineation of Clinical Target Volume for Intensity-Modulated Pelvic Radiotherapy in Postoperative Treatment of Endometrial and Cervical Cancer
2007
A Phase II Study of Bevacizumab in Combination With Definitive Radiotherapy and Cisplatin Chemotherapy in Untreated Patients With Locally Advanced Cervical Carcinoma: Preliminary Results of RTOG 0417
2012
Interim analysis of a prospective phase I/II trial of SBRT for liver metastases
2006
Observation of a Dose–Control Relationship for Lung and Liver Tumors After Stereotactic Body Radiation Therapy
2008
A phase I trial of stereotactic body radiation therapy (SBRT) for liver metastases
2005
How should we describe the radiobiologic effect of extracranial stereotactic radiosurgery: Equivalent uniform dose or tumor control probability?
2003
Clinical potential of bevacizumab in the treatment of metastatic and locally advanced cervical cancer: current evidence
2014
Establishing a framework for building multidisciplinary programs
2015
A phase I/II trial of stereotactic body radiation therapy (SBRT) for lung metastases: Initial report of dose escalation and early toxicity
2006
Stereotactic body radiation therapy. Rationale, techniques, applications, and optimization.
2004
Multi-Institutional Phase I/II Trial of Stereotactic Body Radiation Therapy for Liver Metastases
2009
Multi-Institutional Phase I/II Trial of Stereotactic Body Radiation Therapy for Lung Metastases
2009 Standout
Intrafractional prostate motion assessed by ultrasonic localization: implications for prostate planning target volume construction
2002
Phase I feasibility and dose escalation multicenter trial of stereotactic body radiation therapy for liver metastases
2004
Hypofractionated extracranial stereotactic radiotherapy for liver tumors
2003